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ABSTRACT
Background: Predicting time to relapse provides an opportunity for the development of relapse
prevention interventions in drug users. Objectives: The aim of the present study was to describe the
development of the Persian version of the 9-item Time to RelapseQuestionnaire (TRQ) and to evaluate
its psychometric properties in an Iranian sample of treatment-seeking individuals with substance
dependence (n = 150). Methods: The forward–backward method was used to translate the TRQ scale
from English into Persian. After linguistic validation and a pilot check, a cross-sectional study was
performed, and psychometric properties of the Iranian version of the questionnaire were assessed.
The reliability was evaluated by Cronbach’s alpha and test–retest analyses. In addition, the factor
structure of the scale was extracted by applying confirmatory factor analysis. Results: The mean age of
participants was 40.52 (SD = 11.30) years. The mean scores for the content validity index (CVI) and the
content validity ratio (CVR) were 0.93 and 0.81, respectively. A confirmatory factor analysis (CFA)
demonstrated that the three-factor model of the TRQ was a good fit for the data and thus replicated
the factor structure of the original English language TRQ. Cronbach’s alpha presented good internal
consistency (alpha = 0.76), and test–retest reliability of the TRQ instrument with 2-week intervals was
appropriate (ICC = 0.84). Conclusion: The findings demonstrate that the Persian version of the TRQ is a
reliable and valid scale for measuring time to relapse in Iranian drug users. The TRQ can be applied at
the start of treatment so that clinical interventions can be targeted toward the different relapse styles.
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Introduction
Drug addiction is a social, psychological, and economic
problem in Iran (1). Iran has a long history of sub-
stance abuse, and the existing documents show that
Iranian people have been familiar with the medical
properties of opiates for centuries (2). In addition to
opium as a traditional drug, other popular drugs
include heroin, synthetic heroin (called Kerack), nor-
gesic, and temgesic; more recently, methamphetamine
use has also been identified as an upcoming drug pro-
blem in Iran (3). There are several reasons for the drug
abuse problem in the country. First, Iran has a long
border with Afghanistan, the largest producer of opium
in the world (4). Second, Iran is located on a drug
transportation route (1,5,6). Consequently, it is esti-
mated that at least 1.2 million people in Iran are cur-
rently addicted to drugs (7). Besides needing
appropriate diagnostic and therapeutic instruments,
this huge number of drug addicts would also benefit
from treatment services (8). Many different types of
drug use treatment are available in Iran, such as a
short-term medical detoxification with clonidine or
naltrexone, ultra-rapid detoxification, buprenorphine
maintenance treatment, methadone maintenance treat-
ment, opium tincture substitution therapy, naltrexone
maintenance treatment, Narcotics Anonymous treat-
ment centers, residential centers (camps), matrix
model intensive outpatient programs, and therapeutic
communities for methamphetamine use treatment (3).
Additionally, relapse prevention programs are available
in some private and public addiction treatment centers.
Since addiction is identified as a chronic, relapsing
disease, relapse is acknowledged as a major challenge
for addiction therapists (9,10). Despite the development
of various treatments for addiction in Iran, a significant
number of patients return to drug use behavior. For
instance, in a study conducted by Mohammadpoorasl
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et al., the rate of relapse after six months of treatment
was 64% (11), while a study by Shirinbayan (12) found
that six-month retention in methadone maintenance
treatment (MMT) was only 22.7%. Other Iranian stu-
dies have determined a high rate of relapse (between
75% and 95%) (13,14). Since longer retention is related
to the effectiveness of addiction treatment, a high rate
of relapse can be identified as a barrier to drug addic-
tion treatment (15,16).
Therefore, relapse prevention interventions designed
by therapists and tailored to the relapse risk of the
individual patient are a priority. The results of one
study on relapse prevention showed that relapse pre-
vention programs reduced relapse in Iranian drug users
(17). However, a major limitation in designing relapse
prevention interventions is the limited availability of
psychometric instruments to measure relapse written
in the Persian language. Although several researchers
have attempted to develop reliable and valid instru-
ments to assess relapse in drug users (18–20), most of
them suffer problems in assessing the time to relapse
for alcohol and drug use. Therefore, Adinoff and col-
leagues designed the Time to Relapse Questionnaire
(TRQ) to assess the time from one’s initial thought of
drug use to actual use (21). TRQ is a self-reported,
clear, and reliable instrument in settings of addiction
treatment, and it is useful for patients with previous
experience of relapse. The main value of the question-
naire is that it may predict what patients will relapse
without forewarning compared to those who will do so
with a period of delay. This would provide an oppor-
tunity to target therapy toward a patient’s specific
relapse risk. To our knowledge, however, the predictive
validity of this measure has not been empirically vali-
dated. A Persian version of the TRQ could be used to
overcome the lack of a suitable instrument for design-
ing relapse prevention intervention in Iran. Given the
strengths of the TRQ, the aim of this study is to
describe the development of a Persian version of the
TRQ and evaluate the psychometric properties of its
obtained scores in drug-dependent patients.
Methods
The Time to Relapse Questionnaire
The TRQ is a self-report measure that assesses relapse
risk in the drug- and alcohol-dependent population,
using time to relapse as the critical assessment item.
The TRQ consists of nine items and three subscales.
The Sudden Relapse subscale consists of three items
and refers to a fast (e.g., a few minutes) relapse to
drug use. The 3-item Short Delay Relapse subscale
refers to the returning to substance use in a very
short time (i.e., less than one day). The three items on
the Long Delay Relapse subscale reflect major cognitive
control and might show more doubt toward using
drugs. Each item is rated on a 4-point Likert scale:
1 = false, 2 = slightly true, 3 = mainly true, and 4 =
very true. As such, the total score can range from 3 to
12 for each subscale. A score above 9 in a subscale
(Sudden Relapse, Short Delay Relapse, or Long Delay
Relapse) suggests that this subscale is the patient’s main
relapse style. Some examples of items within each of the
subscales include: When I start using drugs again, it’s
not planned (Sudden Relapse), I crave for less than one
day before I start using again (Short Delay Relapse), I
plan for several days before I use(Long Delay Relapse).
The Persian version of the TRQ
Permission to translate the English version of the TRQ
was obtained from the original author (personal commu-
nication). The standard forward–backward method was
used to translate the TRQ from English to Persian (the
Iranian language). For forward translation, two bilingual
professional translators independently translated the
items of the TRQ scale into Persian. Next, these transla-
tions were integrated into a provisional Persian version of
the TRQ. Then, two other professional translators who
had never seen the English version of the questionnaire
translated the Persian version back into English, and an
interim English version of the questionnaire was created.
Thereafter, a professional team comprised of translators,
psychologists, and epidemiologists compared the original
version of the TRQ with the back-translated English ver-
sion. After some cultural and linguistic adaptations, a
preliminary Persian version of the TRQ questionnaire
was prepared. This Persian version was tested in a pilot
study with 20 users, and thereafter, the final Persian ver-
sion of the TRQ scale was solidified and applied in the
present study.
Procedure and participants
The present study used a cross-sectional psychometric
design and was conducted in Sanandaj, a large city in
Iran, during the period of May–December 2014. A
group of substance-dependent patients referred to
drop-in centers (DICs) and methadone maintenance
treatment (MMT) programs were selected using a ran-
domized sampling method. The DICs are run by local
nongovernmental organizations (NGOs) offering thera-
pies and psychosocial support and facilitating self-help
groups. Inclusion criteria in this study were: (a) being
dependent on drugs in accordance with the Diagnostic
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and Statistical Manual of Mental Disorders, Fifth
Edition (DSM-5), (b) having a history of previous treat-
ment and experience of relapse, and (c) having no
history of psychiatric disease. According to Gable and
Wolf (22), the necessary sample size for a study can be
determined by the number of questionnaire items mul-
tiplied by 10 (in this study, 9 × 10 = 90). Thus, the
sample size of 150 in the initial study was adequate for
the analyses employed. A multistage cluster sampling
method was used. Firstly, Sanandaj was separated into
five areas: north, south, west, east, and central. All
MMT programs and DICs located in these five areas
were recognized. Then, for each area, four MMT pro-
grams and one DIC were randomly chosen, and six
people were approached at each of them. Additionally,
40 substance-use-dependent patients from the MMT
programs and DICs completed the questionnaire twice
in a two-week interval. After an interview and a short
explanation about the study, patients who agreed to
participate in this study were asked to answer the
Iranian version of the TRQ questionnaire. If partici-
pants were illiterate, the researcher read them the ques-
tions and recorded their answers.
The mean age of the participants was 40.52 years
(SD = 11.30). Most participants (n = 98, or 65.3%)
were illiterate or had only achieved a primary educa-
tion level. Of the participants, 23.3% (n = 35) were
unemployed. Of the 76.7% of the sample who had a
job, about 54.7% worked full time. Regarding marital
status, about 26.0% were single, 58.7% were mar
ried, and 15.3% were divorced. The demographic
characteristics of the participants are presented in
Table 1. Table 2 presents the drug-use patterns of the
participants. Opium and opium juice, heroin, and amphe-
tamine-based drugs were the main current drug of abuse.
Although, 55.3% of the patients (n = 83) were polydrug
abusers who used at least three substances in an indis-
criminant way, 26% of the participants (n = 39) used only
two substances. Furthermore, 18.7% of the patients (n =
28) had a history of injection drug use. All patients had
experienced previous treatment; the most common treat-
ment goal was an abstinence regimen.
Analytic strategy
Psychometric properties of the Persian version of the
TRQ questionnaire were evaluated by assessing the inter-
nal and test–retest reliabilities; determining the content,
face, and construct validities; and by examining the factor
structure.
Reliability
Cronbach’s alpha coefficient was used as a measure to
assess the internal consistency of the questionnaire.
Values equal to or above 0.70 are often considered to be
satisfactory. However, Fitzner (2007) considered a
respectable reliability to be between 0.70 and 0.80 and a
very good reliability to be between 0.80 and 0.90 (23).
Furthermore, to evaluate the questionnaire’s stability,
test–retest reliability was measured using the intraclass
correlation coefficient (ICC). The ICC is a measure for
Table 1. Demographic characteristics of the study sample (n = 150).
Face validity sample (n = 10) Pilot study sample (n = 20) CFA sample (n = 150)
Test–retest sample
(n = 40)
Number (%) Number (%) Number (%) Number (%)
Age (years)
30 ≤ 1 (10.0) 6 (30.0) 27 (18.0) 13 (32.5)
31–45 2 (20.0) 7 (35.0) 80 (53.3) 21 (52.8)
46–60 6 (60.0) 5 (25.0) 36 (24.0) 4 (10.0)
61 and above 1 (10.0) 2 (10.0) 7 (4.7) 2 (5.0)
Mean (SD) 41.87 (9.27) 40.52 (8.63) 40.52 (11) 36 (9.88)
Range 18–65 24–72 19–78 21–67
Employment status
Jobless 2 (20.0) 6 (30.0) 35 (23.3) 9 (22.5)
Full time 6 (60.0) 5 (25.0) 82 (54.7) 25 (62.5)
Part time 2 (20.0) 9 (45.0) 33 (22.0) 6 (15.0)
Income (in Iranian Rial)
500.0000 < 4 (40.0) 14 (70.0) 90 (60.0) 19 (47.5)
500.0000–1.000.0000 3 (30.0) 5 (25.0) 49 (32.7) 16 (40.0)
1.000.0000> 3 (30.0) 1 (5.0) 11 (7.3) 5 (3.5)
Educational status
Primary 3 (30.0) 12 (60.0) 98 (65.3) 20 (50.0)
Secondary 5 (50.0) 6 (30.0) 39 (26.0) 12 (30.0)
Higher 2 (20.0) 2 (10.0) 13 (8.7) 8 (20.0)
Marital status
Divorced/widowed 1 (10.0) 8 (40.0) 23 (15.3) 7 (17.5)
Married 6 (60.0) 7 (35.0) 88 (58.7) 16 (40.0)
Single 3 (30.0) 5 (25.0) 39 (26.0) 17 (42.5)
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estimating the reliability where the unit of analysis is the
individual rating, whereas Cronbach’s alpha is a measure
for estimating reliability where the unit of analysis is the
mean of all the ratings (24). ICC values equal to or higher
than 0.40 are considered to be acceptable (r’s between 0.81
and 1.0 are excellent, between 0.61 and 0.80 are very good,
between 0.41 and 0.60 are good, between 0.21 and 0.40 are
fair, and between 0.00 and 0.20 are poor) (25).
Validity
The content, face, and construct validities of the
Persian version of the TRQ questionnaire were evalu-
ated in the following ways.
Content validity
Both qualitative and quantitative methods were used to
assess the content validity of the questionnaire. In a quali-
tative step, an expert panel consisting of two psychometric
experts and five health professionals in the fields of health
education and promotion, psychology, addiction therapy,
and social medicine evaluated the grammar, wording, item
allocation, and scaling of the TRQ questionnaire. The con-
tent validity index (CVI) and the content validity ratio
(CVR) were assessed in a quantitative phase. To determine
the CVI, the specialists were invited to assess each item
based on relevance, clarity, and simplicity using a 4-point
Likert-type scale ranging from 1 = not relevant, not simple,
and not clear to 4 = very relevant, very simple, and very clear.
A CVI score of 0.80 or above for each item was considered
to be acceptable (26). The necessity of the items was eval-
uated by calculating the CVR, by which experts evaluated
items as essential, useful but not essential, or unessential
(27) based on the Lawshe Table (28); items with a CVR
score below 0.40 were assumed to be not acceptable.
Face validity
In order to assess the face validity, both quantitative and
qualitative methods were used. A group of drug users
with different demographic characteristics and drug
addictions (n = 10) were asked to assess each item of
the questionnaire on “ambiguity,” “difficulty,” and “rele-
vance.” Revisions were made based on the participants’
recommendations. In addition, a similar group of parti-
cipants (n = 10) was asked to assess the importance of
each item on a 5-point Likert scale. We then calculated
impact scores (frequency × importance) and considered
an impact score of 1.5 or below to be unsuitable (29).
Construct validity
A confirmative factor analysis (CFA) was applied to deter-
mine the underlying constructs of the Iranian version of the
TRQquestionnaire. Themodel fit of theCFAwas evaluated
according to several fit indices. We reported a χ2/df ratio.
An χ2/df ratio between 2:1 and 5:1 is required for an
acceptable fit; however, values of less than 3:1 are preferred
(Kline, 2005). In addition, we examined theGoodness of Fit
Index (GFI), the Non-Normed Fit Index (NNFI), the
Normed Fit Index (NFI), the Root Mean Square Error of
Approximation (RMSEA), and the Standardized Root
Mean Square Residual (SRMR) (30,31). The NNFI and
the NFI range from 0 to 1.00. Values of 0.95 or higher
indicate that a model provides a good fit while a value of
at least 0.90 indicates that the model provides an adequate
fit. RMSEA values below 0.05 indicate a good model fit
while values between 0.06 and 0.08 indicate an adequate fit.
The SRMR is a standardized summary of the average cov-
ariance residuals (32); a relatively good model fit is indi-
cated when the SRMR is less than 0.08.
Ethics
It was made clear at the beginning of the study that the
respondents were under no obligation to participate
and that they were allowed to leave the study at any
time. Furthermore, the purpose and procedure of the
study were explained to all participants, and their writ-
ten informed consent was obtained. Ethical approval of
this study was given by the Medical Ethics Committee
of Kurdistan University of Medical Sciences.
Results
Reliability
The internal reliability of the questionnaire was measured
using Cronbach’s alpha. All values were above acceptable
thresholds, with alpha = 0.76 for the total questionnaire
and alpha’s ranging between 0.72 and 0.79 for its sub-
scales. Furthermore, the ICC was 0.85 for the total ques-
tionnaire, with ICC values ranging from 0.805 to 0.915
for the subscales, lending support to the stability of the
scales. The findings are displayed in Table 3.
Table 2. Drug-use patterns of the study sample (n = 150).
Drugs used Number Percent
Type of drug
Opium 62 41.4
Heroin 56 37.3
Crystal meth 5 3.3
Crack 2 1.3
Tramadol 3 2.0
Methadone 22 14.7
Injection
Yes 28 18.7
No 122 81.3
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Content and face validity
The CVI and CVR, two measures of content validity,
were good (CVI = 0.93 and CVR = 0.81). In order to
examine the face validity of the (sub)scales, impact
scores were measured. The values were equal to or
above 1.5 (ranging from 1.5 to 4.7) for the items. So,
all items were kept in this phase (see the Method sec-
tion above).
Construct validity
The construct validity was tested using a confirmatory
factor analysis conducted on the multi-item scale in
order to identify whether the indicators adequately
measured the three constructs. The factors were con-
sistent with the original TRQ (Adinoff, Talmadge et al.,
2010), with factor 1 (Sudden Relapse) including three
items (items 1, 4, and 8); factor 2 (Long Delay Relapse)
including three items (items 3, 5, and 9); and factor 3
(Short Delay Relapse) including three items (items 2, 6,
and 7). The model fit the data well, with χ2/df = 1.64,
RMSEA = 0.066 (90% CI = 0.021–0.089), SRMR= 0.03,
GFI = 0.94, NNFI= 0.95, and NFI = 0.98. As shown in
Figure 1, factor loadings ranged from 0.61 to 0.72 for
the Short Delay Relapse construct, from 0.71 to 0.78 for
the Sudden Relapse construct, and from 0.72 to 0.78 for
the Long Delay Relapse construct.
Discussion
This study described the development of a Persian
version of the Time to Relapse Questionnaire (TRQ)
and its psychometric properties. The original English
version of the TRQ was translated and adapted into
Persian in order to fill the absence of a validated instru-
ment to measure time to relapse in Iranian drug users.
To the best of our knowledge, the Persian TRQ is the
first translated version of the original English TRQ.
Consistent with the original English version of the
TRQ (21), three factors were found: Sudden Relapse,
Table 3. Reliability estimates for the TRQ subscales.
Factor Name of factor Number of items Cronbach’s α ICC (n = 40)
1 Long Delay Relapse 3 items (3, 5, 9) 0.79 0.915
2 Short Delay Relapse 3 items (2, 6, 7) 0.72 0.823
3 Sudden Relapse 3 items (1, 4, 8) 0.78 0.805
Total 9 items 0.763 0.847
Figure 1. Confirmatory factor analysis of the TRQ.
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Short Delay Relapse, and Long Delay Relapse. Overall,
the results demonstrated that the Persian version of the
TRQ is valid and reliable for evaluating the time to
relapse in drug users. Cronbach’s alpha coefficient of
the Persian TRQ was 0.76, indicating that the reliability
was good. This finding is similar to the results reported
by Adinoff and colleagues, the developers of the origi-
nal English questionnaire. In their study, the authors
reported a Cronbach’s alpha of 0.61 for the full scale
and between 0.64 and 0.75 for the subscales (21).
Furthermore, in the present study, the ICC was 0.85,
which was higher than that of the English version
(2010). As such, it can be concluded that the Persian
version of the TRQ has excellent reliability.
We observed three subscales in the confirmatory
factor analysis, which were similar to those reported
by Adinoff and colleagues. This may have been due to
the drug-using features of the samples in both studies.
The reason for high values of GFI, AGFI, and RMSEA
might be that they could be impacted by sample size,
which in this study was relatively satisfactory (33).
Items comprising the Sudden Relapse factor suggest a
surprising and fast (a few minutes) return to drug use.
There might be some important factors of desire, asso-
ciated with the personal need, for a drug, like positive
expectancies for drug use or lack of control over sub-
stance use. The Short Delay Relapse subscale refers to a
return to substance use in a very short time (less than
one day). Some interventions might therefore consist of
methods like relaxing, doing hobbies, or talking with
psychotherapists. Items related to the Long Delay
Relapse subscale reflect major cognitive control and
might show more doubt toward using drugs. Relapse
might be more affected by certain factors, such as desire,
ecological stressors, and positive mood conditions.
Besides the aforementioned interventions, patients in
this stage might have adequate time to see their psy-
chotherapist. Therefore, the TRQ should be applied at
the start of treatment in order to identify relapse styles.
Although the TRQ among the study sample was
found to be reliable and valid, reporting one general
time to relapse score is better than reporting scores for
the different subscales because various cross loadings
were found between the subscales. This recommenda-
tion is similar to those of the developers of the original
English TRQ.
The present study had some limitations. Firstly, due
to the inaccessibility and problems related to stigma in
women, this study included only men who were depen-
dent on drugs. Hence, corroboration of our findings
with data from both female and male patients would
lend additional credibility to the findings. Secondly, the
age of the patients in this study was 18 to 78 years.
Future studies should recruit patients younger than 18
years. Additionally, using the original English version
of the instrument during the translation process could
have created reaction bias due to the cultural differ-
ences between the United States and Iran. Additional
studies with patients from different sociocultural con-
texts and backgrounds might reveal interesting results.
Another major limitation of this study was that drug
users with psychiatric disorders were excluded. This
limits the generalizability of our findings.
Furthermore, we didn’t follow up with participants to
investigate the predictive validity of the scale. This
might be a direction for future research. Furthermore,
it might be interesting for future studies to examine
evidence of the convergent and discriminant validity of
the scores of the Persian version of the TRQ by exam-
ining associations with scores of other relevant mea-
sures, such as impulsivity or executive function.
In summary, the findings from this study demon-
strated that the Persian version of the TRQ question-
naire is a reliable and valid scale for measuring time to
relapse in Iranian patients with a drug dependency
history.
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